Effectiveness: A 2022 review of seven studies found that these drugs may be effective for weight loss in people with obesity, but results were less significant (in this case, less than 5% of body weight) than other drug classes
Ultimately, lower prices for GLP1 drugs do strengthen the case for expanding coverage in Medicare, and they also make it more feasible for other payers like Medicaid and private insurers to consider broader coverage, Kim said
Some breeze through dose escalation
Estimated costs (in $CDN) of Ozempic, Wegovy, Mounjaro and Zepbound) Here are the current estimated costs per pen of Semaglutide and Tirzepatide as of Nov 2025: Ozempic (Semaglutide) 1 mg ~ $290 Wegovy (Semaglutide) 2.4 mg ~ $480 Moujaro & Zepbound (Tirzepatide) 15 mg ~ $975 (*~ $590 ) *Zepbound (and Mounjaro) cost can be reduced by 40% by enrolling at myzepbound.ca or mymounjaro.ca The monthly cost of these medications depends on your dose
The differences lie in the inactive ingredients (excipients), the delivery method (vials and syringes instead of proprietary auto-injector pens), and the regulatory pathway
No third-party reviews yetVerified Aug 1, 2026SourceVisit site$349/mo all-in monthly they advertise $199 ShedCert
